Fund Description: Global X Longevity Thematic ETF is an exchange-traded index fund or Index ETF which is a separate investment portfolio of the Global X Funds, an open-end investment management company. INVESTMENT OBJECTIVE: The Global X Longevity Thematic ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. INDEX DESCRIPTION: The Indxx Global Longevity Thematic Index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services (collectively, Longevity Companies), as defined by INDXX, the Index Provider. The eligible universe of the Index includes the most liquid and investable companies in accordance with the standard market capitalization and liquidity criteria associated with developed markets. The Index may include components from the following countries: Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, South Korea, the United Kingdom and the United States. From the eligible universe, the Index Provider identifies Longevity Companies by applying a proprietary analysis that consists of two primary components: theme identification and company analysis. The following five themes are expected to provide the most exposure to Longevity Companies: (1) Health Care Products (2) Health Care Services, (3) Medical Devices, and (4) Senior Homes (collectively, Longevity Themes). Companies are analyzed based on two primary criteria: revenue exposure and primary business operations. The Index is weighted according to a modified capitalization weighting methodology and is reconstituted and rebalanced annually. The Index may include large-, mid- or small-capitalization companies, and components primarily include health care, biotechnology and pharmaceuticals companies as well as real estate investment trusts (REITs). FUND STRATEGY: The Adviser uses a passive or indexing approach to try to achieve the Fund’s investment objective. Unlike many investment companies, the Fund does not try to outperform the Index and does not seek temporary defensive positions when markets decline or appear overvalued. The Fund invests at least 80% of its total assets in the securities of the Index. The Fund generally will use a replication strategy. A replication strategy is an indexing strategy that involves investing in the securities of the Index in approximately the same proportions as in the Index. However, the Fund may utilize a representative sampling strategy with respect to the Index when a replication strategy might be detrimental or disadvantageous to shareholders, such as when there are practical difficulties or substantial costs involved in compiling a portfolio of equity securities to replicate the Index, in instances in which a security in the Index becomes temporarily illiquid, unavailable or less liquid, or as a result of legal restrictions or limitations (such as tax diversification requirements) that apply to the Fund but not the Index. FUND MANAGEMENT: Global X Management Company LLC serves as the investment adviser to the Fund.